Liver Cirrhosis

"Liver Cirrhosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Descriptor ID	D008103
MeSH Number(s)	C06.552.630
Concept/Terms	Liver Cirrhosis Liver Cirrhosis Cirrhosis, Liver Cirrhoses, Liver Liver Cirrhoses Hepatic Cirrhosis Cirrhoses, Hepatic Cirrhosis, Hepatic Hepatic Cirrhoses Fibrosis, Liver Fibrosis, Liver Fibroses, Liver Liver Fibroses Liver Fibrosis

Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Liver Cirrhosis [C06.552.630]

Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Cirrhosis" by people in this website by year, and whether "Liver Cirrhosis" was a major or minor topic of these publications.

Bar chart showing 119 publications over 25 distinct years, with a maximum of 13 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	1	0	1
1999	0	1	1
2002	0	2	2
2003	0	2	2
2005	3	2	5
2006	3	0	3
2007	1	0	1
2008	3	0	3
2009	1	3	4
2011	1	0	1
2012	2	2	4
2013	13	0	13
2014	4	1	5
2015	6	2	8
2016	5	1	6
2017	4	2	6
2018	3	2	5
2019	4	0	4
2020	7	2	9
2021	3	0	3
2022	0	6	6
2023	3	7	10
2024	4	5	9
2025	5	2	7

Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.

Mohamed MR, Zhao G, Volkert I, Molinaro A, Schneider CV, Strnad P, Hengstler JG, Xu C, Davis RJ, Schneider KM, Cubero FJ, Trautwein C. Differential Protective Roles of c-Jun N-terminal Kinase-2 in Nonparenchymal Liver Cells and Hepatocytes During Cholestasis. Cell Mol Gastroenterol Hepatol. 2025; 19(11):101588.

View in: PubMed
Colletta A, Cooper KM, Placentino G, Devuni D, Colletta C. Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic liver disease and type 2 diabetes. Front Endocrinol (Lausanne). 2025; 16:1531295.

View in: PubMed
Mohanty A, Austad K, Bosch NA, Long MT, Nolen-Doerr E, Walkey AJ, Drainoni ML, Rizo I, Fantasia KL. Assessing Clinician Engagement With a Passive Clinical Decision Support System for Liver Fibrosis Risk Stratification in a Weight Management Clinic. Endocr Pract. 2025 Jul; 31(7):899-905.

View in: PubMed
Li W, Sparks RP, Sun C, Yang Y, Pantano L, Kirchner R, Arghiani N, Weilheimer A, Toles BJ, Chen JY, Moran SP, Barrera V, Li Z, Zhou P, Brassil ML, Wrobel D, Ho Sui SJ, Aspnes G, Schuler M, Smith J, Medoff BD, Zhou C, Boustany-Kari CM, Rippmann JF, Santos DM, Doerner JF, Mullen AC. Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells. Nat Commun. 2025 Mar 02; 16(1):2109.

View in: PubMed
Giri S, Ingawale S, Khatana G, Gore P, Praharaj DL, Wong VW, Huang DQ, Singhal A, Choudhury A. Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia-Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021. J Gastroenterol Hepatol. 2025 May; 40(5):1188-1201.

View in: PubMed
Ruscetti M. Lineage tracing senescence in?vivo shows not all senescent cells are created equal. Dev Cell. 2025 01 06; 60(1):3-4.

View in: PubMed
Watson BR, Paul B, Rahman RU, Amir-Zilberstein L, Segerstolpe ?, Epstein ET, Murphy S, Geistlinger L, Lee T, Shih A, Deguine J, Xavier RJ, Moffitt JR, Mullen AC. Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution. Nat Commun. 2025 01 02; 16(1):319.

View in: PubMed
Babuta M, Morel C, de Carvalho Ribeiro M, Calenda C, Ortega-Ribera M, Thevkar Nagesh P, Copeland C, Zhuang Y, Wang Y, Cho Y, Joshi R, Brezani V, Hawryluk D, Datta AA, Mehta J, Nasser I, Szabo G. Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis. Gut. 2024 Oct 07; 73(11):1854-1869.

View in: PubMed
Cho EJ, Chung GE, Yoo JJ, Cho Y, Lee KN, Shin DW, Kim YJ, Yoon JH, Han K, Yu SJ. Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups. Cardiovasc Diabetol. 2024 09 12; 23(1):340.

View in: PubMed
Friedline RH, Noh HL, Suk S, Albusharif M, Dagdeviren S, Saengnipanthkul S, Kim B, Kim AM, Kim LH, Tauer LA, Baez Torres NM, Choi S, Kim BY, Rao SD, Kasina K, Sun C, Toles BJ, Zhou C, Li Z, Benoit VM, Patel PR, Zheng DXT, Inashima K, Beaverson A, Hu X, Tran DA, Muller W, Greiner DL, Mullen AC, Lee KW, Kim JK. IFN?-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease. Nat Commun. 2024 Jun 29; 15(1):5506.

View in: PubMed

People

Explore

Similar Concepts

Top Journals